MedTech Innovator

Neurava is a company focused on developing non-invasive wearable diagnostic devices for patients with epilepsy, particularly those at risk of Sudden Unexpected Death in Epilepsy (SUDEP). The company's innovative device monitors critical biological signals related to epilepsy, providing timely alerts to caregivers and patients. By offering a reliable monitoring solution, Neurava aims to enhance patient autonomy and deliver peace of mind to families, facilitating timely intervention when necessary. The company's work lies at the intersection of medical device manufacturing and health diagnostics, addressing a significant need within the epilepsy patient community.

Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.

Neurava is a company focused on developing non-invasive wearable diagnostic devices for patients with epilepsy, particularly those at risk of Sudden Unexpected Death in Epilepsy (SUDEP). The company's innovative device monitors critical biological signals related to epilepsy, providing timely alerts to caregivers and patients. By offering a reliable monitoring solution, Neurava aims to enhance patient autonomy and deliver peace of mind to families, facilitating timely intervention when necessary. The company's work lies at the intersection of medical device manufacturing and health diagnostics, addressing a significant need within the epilepsy patient community.

Universal Brain is focused on creating individualized treatments for mental health by utilizing advanced neurofeedback therapy methods. The company engages in research and development of algorithms that integrate data from electroencephalograms (EEG) and magnetic resonance imaging (MRI) through deep learning techniques. This approach allows for the design and manufacturing of portable electroencephalograph headsets, enhancing the capabilities of mental health professionals in diagnosing and treating psychiatric conditions. By analyzing brain data, Universal Brain aims to provide valuable insights that improve the effectiveness of psychiatric care.

EPIC Neuro is focused on creating a small, leadless device designed for brain stimulation and cortical EEG recording to aid in stroke recovery. The device is powered externally through a headset or handheld module, making it simple to implant and eliminating the need for battery replacements. Its minimally invasive design ensures that it is inexpensive, easily removable, and safe for MRI procedures. This innovation aims to provide a hassle-free recovery experience for patients suffering from stroke symptoms.

EPIC Neuro is focused on creating a small, leadless device designed for brain stimulation and cortical EEG recording to aid in stroke recovery. The device is powered externally through a headset or handheld module, making it simple to implant and eliminating the need for battery replacements. Its minimally invasive design ensures that it is inexpensive, easily removable, and safe for MRI procedures. This innovation aims to provide a hassle-free recovery experience for patients suffering from stroke symptoms.

Incereb is an Irish medical device company based in Dublin, specializing in the neonatal intensive care unit (NICU) market. Founded in May 2011, the company focuses on designing and developing disposable Electroencephalography (EEG) and Cerebral Function Monitoring (CFM) products tailored for term and preterm infants. These innovative products require minimal training for medical professionals, significantly simplifying the setup process for monitoring neonates. Incereb's devices are compatible with various EEG and CFM recording equipment, enhancing their versatility in clinical settings. The company is committed to investing in research and development to expand its product offerings and has established strategic partnerships with leading Irish universities and hospitals. These collaborations aim to harness local scientific expertise, facilitating the quick commercialization of new devices and supporting the company’s growth trajectory.

HeadSense Medical Ltd. is an early-stage company based in Netanya, Israel, focused on developing non-invasive diagnostic devices for brain health. Established in 2011, the company has created a validated and CE Mark approved intracranial pressure (ICP) monitor that is applicable in various medical fields, including neurosurgery, neurology, emergency medicine, and critical care. The device allows healthcare professionals to diagnose and monitor critical clinical parameters without the need for invasive procedures. In addition to its ICP monitor, HeadSense is actively working on expanding its product offerings to include diagnostic tools for cerebral vasospasm, concussion, and the quantification of traumatic brain injury severity, among others. The company operates in both the U.S. and Israel, aiming to enhance patient outcomes through innovative monitoring solutions.